147 related articles for article (PubMed ID: 12000833)
1. Epstein-Barr virus nuclear antigen 5 inhibits pre-mRNA cleavage and polyadenylation.
Dufva M; Flodin J; Nerstedt A; Rüetschi U; Rymo L
Nucleic Acids Res; 2002 May; 30(10):2131-43. PubMed ID: 12000833
[TBL] [Abstract][Full Text] [Related]
2. Epstein-barr virus nuclear antigen 2 retards cell growth, induces p21(WAF1) expression, and modulates p53 activity post-translationally.
Lin CS; Kuo HH; Chen JY; Yang CS; Wang WB
J Mol Biol; 2000 Oct; 303(1):7-23. PubMed ID: 11021966
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element.
Fåhraeus R; Jansson A; Ricksten A; Sjöblom A; Rymo L
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7390-4. PubMed ID: 2170976
[TBL] [Abstract][Full Text] [Related]
4. Identification of the Epstein-Barr virus nuclear antigen 2 transactivation domain.
Horvath GC; Schubach WH
Biochem Biophys Res Commun; 1993 Feb; 191(1):196-200. PubMed ID: 8383488
[TBL] [Abstract][Full Text] [Related]
5. 3' RNA processing efficiency plays a primary role in generating termination-competent RNA polymerase II elongation complexes.
Edwalds-Gilbert G; Prescott J; Falck-Pedersen E
Mol Cell Biol; 1993 Jun; 13(6):3472-80. PubMed ID: 7684499
[TBL] [Abstract][Full Text] [Related]
6. Identification of intracellular proteins associated with the EBV-encoded nuclear antigen 5 using an efficient TAP procedure and FT-ICR mass spectrometry.
Forsman A; Rüetschi U; Ekholm J; Rymo L
J Proteome Res; 2008 Jun; 7(6):2309-19. PubMed ID: 18457437
[TBL] [Abstract][Full Text] [Related]
7. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944
[TBL] [Abstract][Full Text] [Related]
8. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
Gross H; Barth S; Pfuhl T; Willnecker V; Spurk A; Gurtsevitch V; Sauter M; Hu B; Noessner E; Mueller-Lantzsch N; Kremmer E; Grässer FA
Int J Cancer; 2011 Sep; 129(5):1105-15. PubMed ID: 21710493
[TBL] [Abstract][Full Text] [Related]
9. Repression of the viral latent promoter BC-R2 in Epstein-Barr virus negative cell lines.
Klonjkowski B; Walls D; Gilardi-Hebenstreit P; Perricaudet M
Biochem Biophys Res Commun; 1992 Dec; 189(3):1695-700. PubMed ID: 1336378
[TBL] [Abstract][Full Text] [Related]
10. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel promoter located within the Bam HI Q region of the Epstein-Barr virus genome for the EBNA 1 gene.
Tsai CN; Liu ST; Chang YS
DNA Cell Biol; 1995 Sep; 14(9):767-76. PubMed ID: 7669254
[TBL] [Abstract][Full Text] [Related]
12. Role of a consensus AP-2 regulatory sequence within the Epstein-Barr virus LMP1 promoter in EBNA2 mediated transactivation.
Jansson A; Johansson P; Yang W; Palmqvist L; Sjöblom-Hallén A; Rymo L
Virus Genes; 2007 Oct; 35(2):203-14. PubMed ID: 17546492
[TBL] [Abstract][Full Text] [Related]
13. Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells.
Chang MH; Ng CK; Lin YJ; Liang CL; Chung PJ; ChenML ; Tyan YS; Hsu CY; Shu CH; Chang YS
DNA Cell Biol; 1997 Jul; 16(7):829-37. PubMed ID: 9260926
[TBL] [Abstract][Full Text] [Related]
14. Implications of polyadenylation in health and disease.
Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
[TBL] [Abstract][Full Text] [Related]
15. Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences.
Carswell S; Alwine JC
Mol Cell Biol; 1989 Oct; 9(10):4248-58. PubMed ID: 2573828
[TBL] [Abstract][Full Text] [Related]
16. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Nilsson T; Sjöblom A; Masucci MG; Rymo L
Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
[TBL] [Abstract][Full Text] [Related]
17. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
[TBL] [Abstract][Full Text] [Related]
18. RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines.
Zhao B; Maruo S; Cooper A; R Chase M; Johannsen E; Kieff E; Cahir-McFarland E
Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1900-5. PubMed ID: 16446431
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing determines the carboxy terminus of the Epstein-Barr virus nuclear antigen 5 species expressed in the Burkitt's lymphoma cell line Daudi.
Ring CJ; Jones MD; Griffin BE
J Gen Virol; 1992 Oct; 73 ( Pt 10)():2715-9. PubMed ID: 1328484
[TBL] [Abstract][Full Text] [Related]
20. Fine gene expression regulation by minor sequence variations downstream of the polyadenylation signal.
Boldyreva LV; Yarinich LA; Kozhevnikova EN; Ivankin AV; Lebedev MO; Pindyurin AV
Mol Biol Rep; 2021 Feb; 48(2):1539-1547. PubMed ID: 33517473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
